Last reviewed · How we verify
NCT05174988
Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles
NA trial testing Angle stitch in Postoperative Bleeding in 117 participants. Completed in 7 August 2023.
7 August 2023
Quick facts
| Lead sponsor | Texas Tech University Health Sciences Center, El Paso |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 117 |
| Start date | 31 January 2022 |
| Primary completion | 7 August 2023 |
| Estimated completion | 7 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Angle stitch
Conditions studied
- Postoperative Bleeding — all drugs for Postoperative Bleeding →
- Patient Satisfaction — all drugs for Patient Satisfaction →
- Complications — all drugs for Complications →
- Operative Time — all drugs for Operative Time →
Sponsor
Texas Tech University Health Sciences Center, El Paso
Who can join
Adults 18 to 60, female only, with Postoperative Bleeding or Patient Satisfaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators propose prospectively evaluating if adding separate sutures to the angles of the vaginal cuff before running barbed suture reduces the incidence of patient's perception of bleeding after surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05174988
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postoperative Bleeding
Currently open trials in the same condition.
- NCT06969326 — Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy · Phase 3 · recruiting
Other Texas Tech University Health Sciences Center, El Paso trials
Trials by the same sponsor.
- NCT06016465 — Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? · EARLY_PHASE1 · recruiting
- NCT05303116 — Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms? · completed
- NCT05077917 — Cromolyn Sodium for Treatment of COVID-19 Pneumonia · Phase 3 · terminated
- NCT04786379 — Surgical Management of Knee Septic Arthritis · NA · terminated
- NCT04646083 — Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05174988 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Tech University Health Sciences Center, El Paso
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05174988.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing